Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy (Q35696941)
Jump to navigation
Jump to search
scientific article published on 6 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy |
scientific article published on 6 March 2007 |
Statements
1 reference
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy (English)
1 reference
Rodryg Ramlau
1 reference
Vera Hirsh
1 reference
John Glaspy
1 reference
Paul Mainwaring
1 reference
Christian Manegold
1 reference
Joseph E Eid
1 reference
6 March 2007
1 reference
1 reference
8
1 reference
8
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference